Does COVID Weaken Your Immune System Long-Term?

COVID-19 can disrupt your immune system for months after infection, but for most people, it does not cause permanent immune damage. Research shows that certain immune cells remain altered for 8 to 12 months after even a mild infection, with some changes persisting up to two years in people who develop long COVID. The picture is more nuanced than a simple yes or no: the virus reshapes parts of the immune system in ways that differ significantly from person to person, depending on infection severity, vaccination status, and individual biology.

What Happens to Immune Cells After Infection

SARS-CoV-2 affects both major branches of the immune system. On the adaptive side, people who recover from COVID tend to have fewer circulating CD4+ and CD8+ memory T cells for months afterward. These are the cells responsible for recognizing and fighting off specific pathogens you’ve encountered before. In people with long COVID, CD8+ T cells (the ones that kill infected cells directly) remain low even after other T cell populations partially recover.

The virus also pushes T cells toward an exhausted state. Exhausted T cells carry surface markers that essentially act as “off switches,” making them less effective at fighting infections. One study tracking patients for two years found that these exhaustion markers were significantly elevated at 8 months in people with long COVID compared to those who fully recovered. The good news: by 24 months, those exhaustion markers had largely faded, suggesting the effect is not permanent for most people.

B cells, which produce antibodies, are also affected. People with long COVID show reduced levels of a specific subset called switched memory B cells. These are the cells that “remember” past infections and can rapidly produce targeted antibodies when a pathogen returns. Lower levels of these cells could, in theory, make you more vulnerable to infections you’ve fought off before, though this hasn’t been shown to cause the kind of dramatic “immune amnesia” that measles does.

How COVID Reprograms Innate Immune Cells

Beyond T cells and B cells, COVID makes lasting changes to the innate immune system, your body’s first line of defense. A study published in Cell found that severe COVID-19 causes epigenetic changes in the stem cells that produce white blood cells. Epigenetic changes don’t alter DNA itself but change which genes are turned on or off, effectively reprogramming how new immune cells behave.

These changes persisted for 4 to 12 months after infection. Some were “transient,” fading back to normal within months. Others were classified as “persistent,” with altered gene activity at sites related to inflammation, cell activation, and immune signaling lasting a full year. The inflammatory signaling molecule IL-6, which surges during acute COVID, appears to be the key driver. It triggers a chain reaction that reprograms stem cells in the bone marrow, and those stem cells then produce monocytes (a type of white blood cell) that carry forward the altered programming.

The practical consequence is that your innate immune system may remain in a state of heightened or dysregulated inflammation for months. This could explain some long COVID symptoms like fatigue and brain fog, and it may also affect how your body responds to new infections during that window.

Autoantibodies and Self-Attack

One of the more concerning findings is that COVID can trigger the production of autoantibodies, immune proteins that mistakenly target your own tissues. In one study, about 24% of people with long COVID tested positive for at least one autoantibody. Autoantibodies against proteins called G-protein coupled receptors, which play roles in the nervous system and blood vessels, have been detected up to 12 months after infection.

However, the connection between these autoantibodies and actual symptoms remains unclear. In some studies, recovered individuals without lingering symptoms had even higher rates of autoantibody positivity than those with long COVID. Researchers have noted that the contribution of autoantibodies to ongoing symptoms is “likely modest” in many cases, though they may matter more for people with specific neurological complaints.

Children faced a particularly dramatic version of this phenomenon early in the pandemic. About 1 in 2,000 children under 18 with COVID developed multisystem inflammatory syndrome (MIS-C), where the immune system attacked the heart, lungs, kidneys, and other organs. Researchers at UCSF discovered that these children’s immune systems had mistaken a part of the coronavirus for a human protein called SNX8, found throughout the body, and launched an attack on their own tissues. Most children who developed MIS-C have fully recovered, and cases are now rare, occurring mostly in unvaccinated children.

How This Differs From Measles

You may have seen comparisons between COVID and measles, which causes well-documented “immune amnesia.” The two viruses work very differently. Measles directly infects and destroys long-lived immune memory cells in the bone marrow, effectively wiping out your body’s stored knowledge of past infections and vaccines. This can set your immune defenses back by years.

COVID does not appear to cause this kind of wholesale memory erasure. Instead, it causes a temporary suppression and dysregulation of immune responses. T cells become exhausted rather than destroyed, and while certain memory B cell populations drop, the mechanism is fundamentally different from measles wiping out the antibody-producing cells themselves. The risk with COVID is more about months of suboptimal immune function than a reset of your entire immune history.

Recovery Timelines

For people who recover fully from COVID without developing long-term symptoms, most measurable immune abnormalities resolve within 6 to 12 months. T cell exhaustion markers peak around 3 months and begin declining by 6 months. Epigenetic changes in innate immune cells follow a similar arc, with some normalizing within months and others taking up to a year.

For people with long COVID, the timeline stretches further. One study in Nature Immunology found that patients with long COVID still had highly activated innate immune cells, depleted naive T and B cells, and elevated levels of interferons (proteins that drive antiviral inflammation) at 8 months after a mild-to-moderate initial infection. By two years, many of the T cell exhaustion markers had resolved, but some patients continued to show immune profiles distinct from healthy controls.

The severity of the original infection matters. People who were hospitalized or required intensive care tend to show deeper and longer-lasting immune disruption than those with mild cases. But even mild infections can produce measurable immune changes lasting several months.

Vaccination Makes a Measurable Difference

Being vaccinated before infection significantly reduces the risk of the immune dysregulation described above. Vaccinated individuals tend to have more controlled immune responses during acute infection, with fewer cytokine storms and less autoantibody formation. A multicentric analysis across the UK, Spain, and Estonia found that pre-infection vaccination was associated with a markedly lower risk of developing long COVID.

The mechanisms behind this protection likely involve several factors: vaccination reduces viral load during infection, limits the formation of viral reservoirs in the body, and appears to reprogram immune responses in ways that prevent the kind of runaway inflammation that leads to lasting changes. Multiple studies have confirmed that breakthrough infections in vaccinated people consistently produce fewer physical and neuropsychological symptoms compared to infections in unvaccinated individuals.

What This Means in Practice

COVID-19 does not turn healthy people into immunocompromised patients. What it can do is leave your immune system functioning below its baseline for a period of months, potentially up to a year or more in people with long COVID. During that window, you may be more susceptible to other infections or experience lingering inflammation.

The people at highest risk for meaningful, prolonged immune disruption are those who had severe acute infections, those who are unvaccinated, and those who develop long COVID. For the majority of people who have mild infections and are up to date on vaccinations, the immune system appears to recover its normal function within several months, even if some subtle cellular-level changes linger longer. Repeated infections may compound the effect, though long-term data on cumulative immune impact from multiple COVID infections is still being gathered.